ViaCyte to Present at the Jefferies Gene Therapy/Editing Summit
SAN DIEGO, Oct. 20, 2021 /PRNewswire/ -- ViaCyte, Inc., an innovator in cellular therapy and regenerative medicine, announced today that Michael Yang, President & CEO, will present at the Jefferies Gene Therapy/Editing Summit on Wednesday, October 27, 2021 at 11:30 a.m. ET. Mr. Yang will highlight progress with the Company's investigational pancreatic islet cell replacement therapies, including its program focused on the development of gene-edited immune evasive cells for the treatment of diabetes.
A live webcast of this presentation will be available on the Company's News & Events page accessible here: https://viacyte.com/news-events/. A replay will be available on the Company's website following the event.
View original content to download multimedia:https://www.prnewswire.com/news-releases/viacyte-to-present-at-the-jefferies-gene-therapyediting-summit-301404102.html
SOURCE ViaCyte, Inc.